← Leaderboards
Catherine J Pachuk
Nucleonics, Inc.
$1,647,105
Attributed
$1,647,105
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $349.9K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$1,647,105 · 2
By mechanism
U01$1,549,438 · 1
R41$97,667 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Gene Induction /Repression”
- Stephen G Young · J. David Gladstone Institutes$9,517,509
- Dean Sheppard · University Of California San Francisco$8,235,740
- Judy Lieberman · Boston Children'S Hospital$6,772,749
- Tucker O Collins · Brigham And Women'S Hospital$6,135,718
- Michael Karin · University Of California, San Diego$5,783,991
- Anjana Rao · Immune Disease Institute, Inc.$5,529,176
Research focus
Gene Induction /RepressionMessenger RnaPolymerase Chain ReactionInterferonsTissue /Cell CultureVirus ReplicationLaboratory MouseEnzyme Linked Immunosorbent AssayDouble Stranded RnaHepatitis BCooperative StudyThin Layer ChromatographyRna InterferenceSouthern BlottingComplementary DnaLiver CellsNucleosidesInfrared SpectrometryAntiviral AgentsGene ExpressionCircular DichroismCultured CellsChronicCondition
Grant awards (6)
RNAi Mediated Suppression of Hepatitis B Replication$349,943
U01 · FY2007 · AI · contact PI
RNAi Mediated Suppression of Hepatitis B Replication$349,899
U01 · FY2006 · AI · contact PI
RNAi Mediated Suppression of Hepatitis B Replication$347,883
U01 · FY2005 · AI
RNAi Mediated Suppression of Hepatitis B Replication$337,751
U01 · FY2004 · AI
RNAi Mediated Suppression of Hepatitis B Replication$163,962
U01 · FY2003 · AI
Identification of novel antiviral targets using RNAi$97,667
R41 · FY2002 · DA